Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2013
At a glance
- Drugs Imiquimod (Primary) ; Nonoxinol 9 (Primary)
- Indications Basal cell cancer; Vaginal diseases
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 May 2012 New trial record